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Abstract: Risk of a fall is increased in individuals with chronic obstructive pulmonary disease (COPD),
and is usually evaluated using the Berg Balance Scale (BBS), but this is difficult to perform in everyday
clinical practice. We aimed to prospectively predict short-term fall recurrence in COPD patients
using a predetermined cut-off value of the Timed Up and Go test (TUG). In stable COPD patients, we
collected self-reported records of the number of falls in the previous year, and measured TUG and
BBS scores for each individual. Records of fall recurrence were obtained prospectively at 6-months
after the initial evaluation. Among the 50 patients recruited, 23 (46%) had at least one fall during the
past year. The optimal diagnosis value for the TUG to detect a fall was 10.9 s with a sensitivity of
100% and a specificity of 97%. A cut-off of 11 s predicted fall recurrence with high sensitivity and
specificity (93% and 74%, respectively). The TUG as well as the BBS score detected fallers, and a
cut-off value of 11 s predicted fall recurrence. TUG could be easily incorporated into the scheduled
functional evaluations of COPD patients, could predict the risk of a fall and when appropriate, could
guide specific balance training exercises to prevent fall.
Keywords: Chronic obstructive pulmonary disease; Timed Up and Go test; Postural balance; Fall;
Risk factor; Hypoxia
1. Introduction
Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality
worldwide, impacting daily activities and quality of life. Muscle dysfunction, a frequent comorbidity in
individuals with COPD [1], is recognized as one of the risk factors for falls in the elderly. Consequently,
fall risk has recently emerged as a concern in COPD. Roig et al. [2] found an annual rate of 1.2 falls per
COPD patient. In a large cohort of patients from a UK general practice database, 24% of COPD patients
had a fall record, compared to 12% of non-COPD age-matched subjects [3]. In more-severe COPD
patients, falls affected up to 50% of patients entering a pulmonary rehabilitation (PR) program [4], and
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this value was even higher in patients treated with long-term oxygen therapy (LTOT). Importantly, a
history of falls in the previous 6 months is associated with a three-fold increased risk of mortality [5].
Falls are caused by impaired balance control, particularly the biomechanics, transition, and gait
subcomponents of balance [6]. In a systematic review, Oliveira et al. [7] recommended the Berg
Balance Scale (BBS), the Balance Evaluation System test (BEST) and the Activities-specific Balance
Confidence score (ABC-score) to assess balance in COPD patients. In COPD patients, a lower BBS score
is associated with increased risk of fall and is correlated with the severity of bronchial obstruction [8].
Moreover, a difference of 3.5 points (95% confidence interval: −7.0 to −0.2) could separate fallers
from non-fallers [4], and BBS score is responsive to specific balance training incorporated into a PR
program [9]. However, BBS requires approximately 20 min to perform, precluding its utilization in a
large population and during follow-up visits. In contrast, the Timed Up and Go test (TUG) [10] is a
simple, easy to implement, and reproducible test in COPD [11]. Cut-off values of 12 s, proposed to
differentiate fallers from non-fallers in community-dwelling elders, showed good sensitivity [12]. This
threshold has also been demonstrated in pathologies such as Parkinson’s disease, amyotrophic lateral
sclerosis, and post-stroke or orthopedic disturbance [13]. In COPD, the TUG score was also about 3 s
longer in patients who had fallen [4,8]. Similarly, Al Haddad et al. [14] found retrospectively that a
cut-off value of 12 s predicted the occurrence of at least one fall during the previous year in COPD
patients, with a sensitivity and specificity of 74%. Those with a longer TUG score had higher body
mass indexes and Medical Research Council (MRC) dyspnea scores, and a shorter, 6-min walking
distance. After validation in the elderly and in neurological disorders, compelling evidence showed
clinical interest in TUG as a screening assessment of the risk of falling in COPD patients. However, the
sensitivity of TUG to discriminate fallers has never been compared to the reference BBS test, and the
proposed TUG threshold values have not been validated prospectively in COPD.
Our main aim was thus to prospectively establish a cut-off value of TUG to predict falls in the
short term. The secondary aim was to assess consistency of TUG scores relative to BBS scores for risk
of fall screening in COPD patients. Finally, we compared patients with or without chronic respiratory
failure to assess the role of chronic hypoxia.
2. Materials and Methods
2.1. Patients
We recruited outpatients consulting for scheduled COPD follow-up in a respiratory medicine
department. The diagnosis of COPD was made according to the GOLD recommendations on
non-reversible bronchial obstruction using spirometry (with a post bronchodilator FEV1/FVC lower
than 0.7). All the patients gave their written informed consent, and the study was approved by our
local ethics committee (CPP Sud Est 6 2016-A01188-43).
We included patients who had been free of exacerbation in the previous 4 weeks, >3 months after
completion of a respiratory rehabilitation program. Patients older than 80 years were excluded in order
to limit the well-known influence of age on postural balance. In order to obtain patients with variable
severities of disease, we included an equal number of COPD patients with chronic respiratory failure who
were receiving long-term oxygen therapy (LTOT+ group), and patients without hypoxemia (LTOT− group).
All the patients treated with LTOT presented an arterial oxygen pressure below 55 mHg when LTOT was
prescribed but blood gases were not controlled at the time of the study. We excluded patients with a
history of stroke or neurological disorder, unstable heart failure, or lower limb locomotor impairment.
Inclusion and non-inclusion criteria were screened by studying the medical file then carrying out an
interrogation (about medical history in particular) and an extensive clinical examination.
2.2. Methods
All evaluations and tests were performed by one investigator (VR) on the same day and in the
same order. Resting periods were respected between walk tests and muscle strength measurements.
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2.3. Patient Characteristics
• Pulmonary volumes, bronchial airflows, and carbon monoxide lung diffusing capacity (DLCO)
were measured in a body plethysmograph (Sentrysuite, Viasys, Conshohocken, PA, USA),
according to European Respiratory Society recommendations [15]. All the measurements were
compared with the European Community for Coal and Steel (ECCS) predicted values [16]
• Six-minute walking distance (6MWD) was measured according to international recommendations [17].
In patients treated with LTOT, the test was performed with O2 flow prescribed for walking.
• Body composition was determined using biphotonic absorptiometry (Hologic QDR-2000, software
version V5.67A, Hologic Inc., Bedford, MA), with a single scan mode [18,19]. We determined fat mass
(FM) and fat-free mass (FFM). We calculated the FFM index (FFMI, the ratio of FFM over height2, kg
m−2) and skeletal mass index (SMI, the ratio of appendicular FFM over height2, kg m−2).
• Maximal isokinetic concentric strength of quadriceps was measured at 60◦/s (Cybex Norm, USA).
Evaluation was performed in a sitting position according to the manufacturer’s instructions.
Range of motion was set from 90◦ to 0◦ of knee flexion. Before each test, a gravity compensation
procedure was performed. The test consisted of two repetitions for habituation followed after a
resting period by four repetitions at 60◦/s in a concentric mode. The best result was retained as the
peak torque (PT) value and was normalized to patients’ weight.
• Anxiety and depression were evaluated by the Hospital Anxiety and Depression Scale (HADS).
2.4. Balance Assessment and Fall Records
• Timed Up and Go Test (TUG) [10]. Subjects were instructed to stand up from a standard armchair
at the word “go”, walk at a regular pace for 3 m (indicated by a line on the floor), turn around, walk
back, and sit down. This assesses lower limb muscle force, gait speed, and coordination—three
components of postural control. TUG shows excellent intra- and inter-observer reliability, with an
intraclass correlation coefficient of 0.99 [20]. A practice test was followed by the actual test, with
an opportunity to recover between the trials. Gait aids were permitted when appropriate and, for
patients treated with LTOT, the test was performed with O2 flow prescribed for walking that was
carried in a shoulder bag or backpack. A time longer than 12 s is considered as an indicator of fall
risk in the elderly and in COPD patients [14,21].
• The Berg Balance Scale [22] was performed by the same investigator (VR). It comprised 14
questions and tasks completed by patients and scored by the observer, from worst (0) to best (4).
The maximum total score is 56 points, and the risk of fall is considered low above 45.
• The number of falls in the previous year was collected with the Elderly Fall Screening Test
questionnaire [23]. A fall was defined as a positive response to the question “Have you ever found
yourself on the ground without wanting to get there, while sitting, standing or lying down?” We
considered patients as fallers with the occurrence of at least one fall.
• Fall recurrence at 6 months after evaluation was prospectively obtained via a phone survey
using a standardized questionnaire with the same definition as previously used. During this
phone survey, we also assessed whether a rehabilitation program was undertaken during the
observational period.
2.5. Statistical Analysis
We estimated that 40 patients per group were necessary to obtain a BBS score difference of 3.5 ± 5.0
points between fallers and non-fallers for a two-sided type I error at 5% and a statistical power greater
than 80% [4]. An interim analysis was planned in protocol and carried out when half the inclusions
were recruited (i.e., for 20 patients per group). According to (1) these results highlighting an effect size
at 2.77 (95% CI; 1.89; 3.64) and (2) the type I spending function, it was proposed that we limit the study
to 25 patients per group to guarantee a satisfactory statistical power of secondary endpoints.
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All analyses were performed with Stata software (Version 13, StataCorp, College Station, TX, US).
The level of significance was set for a type I error at 5%. Data are presented as mean and standard
deviations. The Shapiro–Wilk’s test was used to test for normality. Concordance of abnormal tests
between BBS and TUG was calculated using Cohen’s kappa coefficient. For abnormality, we used a
cut-off value of 45 for BBS and 12 s for TUG. Sensitivity and specificity values were estimated.
A receiver operating characteristic (ROC) curve analysis was carried out and the best threshold
value of TUG to detect risk of fall was estimated according to clinical relevance and indexes reported
in the literature. The accuracy of this threshold was assessed by ROC curve analyses considering the
recurrence of falls during the follow-up (requiring at least one fall). For comparisons of continuous
variables between fallers and non-fallers, and between LTOT+ and LTOT−, we used Student’s t tests,
or Mann–Whitney U-tests if assumptions of the t-test were not met (normality and homoscedasticity).
Categorical variables were compared between groups using Chi-squared or Fisher’s exact tests.
Multivariable analysis was then performed using generalized linear models (logistic regression for
binary endpoints of (i) past falls and (ii) future falls (6 months after initial evaluation), which were
dichotomized as follows: 0 vs ≥1) to take into account confounder variables. The covariates were
determined using univariate results and clinical relevance (age, gender, BMI, 6MWD, and previous
falls). Particular attention was paid to the study of multicollinearity and interactions between covariates
(1) studying the relationships between the covariables and (2) evaluating the impact of the addition or
deletion of variables on multivariable models. The results were expressed as predicted probabilities
and 95% confidence intervals.
3. Results
3.1. Patient Characteristics
We included 50 COPD patients, 25 each in the LTOT+ and LTOT− groups, respectively.
Twenty-three (46%) patients fell in the previous year (mean number of falls per patient: 2.3 ± 3.9), with
a significantly higher number in the LTOT+ than in the LTOT− group (17 (68%) vs 6 (24%), respectively,
p < 0.005). Patient characteristics, pulmonary function, and body composition compared between
the two groups and in relation to the incidence of fall are detailed in Tables 1 and 2. In the whole
population, HAD scores were on average within normal values but with a large range: 6.5 ± 4.1 (range
0–16) and 5.6 ± 4.0 (range 0–18) points for anxiety and depression, respectively. These scores were not
affected by the LTOT group and faller/non-faller groups.
Table 1. Characteristics of study participants and pulmonary function test results in faller and non-faller
groups, grouped according to long-term oxygen therapy (LTOT) treatment.
All LTOT− LTOT+ Effect of LTOTp Value
Fallers Non-Fallers p Fallers Non-Fallers p In Fallers InNon-Fallers
N 50 6 19 17 8
Age (years) 66.2 ± 8.2 65.0 ± 4.1 64.2 ± 7.3 68.6 ± 9.8 66.4 ± 8.8
BMI (kg m−2) 28.0 ± 6.5 24.2 ± 3.8 26.0 ± 5.5 32.0 ± 7.4 27.0 ± 3.7 0.004
FEV1 % pred 51.8 ± 15.9 63.3 ± 20.4 51.4 ± 15.4 50.0± 15.4 47.6 ± 13.2
FVC % pred 87.1 ± 20.7 88.3 ± 21.1 83.1 ± 19.8 82.6± 15.4 105.4 ± 25.2 0.04 0.04
TLC % pred 123.0 ± 21.7 113.7 ± 31.7 122.2 ± 18.8 118.4± 18.0 141.8 ± 19.8 0.01 0.03
RV/TLC % 55.3 ± 11.6 54.1 ± 8.7 54.1 ± 13.1 57.2± 12.0 55.2 ± 9.6
DLCO % pred 45.5 ± 18.3 38.6 ± 7.5 57.5 ± 19.7 0.01 37.6± 13.0 33.7 ± 15.9
6MWD % pred 79.0 ± 24.2 71.1 ± 15.8 93.8 ± 12.1 0.02 59.6± 26.4 91.0 ± 14.8 0.001 0.03
qPT (Nm/kg) 116.5 ± 37.9 98.1 ± 23.5 134.4 ± 42.3 0.02 95.0± 26.3 133.4± 29.6 0.008
Use of assistive
device (cane) 2 (4%) 0 0 2 (11.7%) 0
Data are given as means ± SD; when significant, p values are given between groups for the effects of fall and of
LTOT). BMI: body mass index; FEV1: Forced Expiratory Volume in 1 s; FVC: Forced Expiratory Volume; TLC:
Total Lung Capacity; RV: Residual Volume; DLCO: diffusing capacity for carbon monoxide; 6MWD: 6-min walking
distance; qPT: quadriceps peak torque; pred: predicted value.
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Table 2. Body composition measured by biphotonic absorptiometry in fallers and non-fallers grouped
according to long-term oxygen therapy treatment.
All LTOT− LTOT+ Effect of LTOTp Value
Fallers Non-Fallers p Fallers Non-Fallers p In Fallers InNon-Fallers
FM (%) 27.8 ± 7.9 28.9 ± 6.2 23.7 ± 8.0 32.5 ± 6.8 26.9 ± 6.5
FFM (kg) 53.1 ± 11.7 44.8 ± 9.8 52.8 ± 12.7 56.6 ± 9.9 52.5 ± 12.6 0.03
FFM (%) 68.8 ± 8.4 68.4 ± 5.8 71.6 ± 10.3 65.0 ± 6.5 70.2 ± 6.2
FFMI (kg·m−2) 20.0 ± 3.4 17.3 ± 3.2 19.8 ± 3.1 0.04 21.3± 19.7 19.7 ± 3.6 0.007
SMI (kg·m−2) 7.7 ± 1.5 6.7 ± 0.9 7.7 ± 1.3 8.1 ± 1.5 7.8 ± 1.7 0.04 0.02
Data are mean ± SD. LTOT−, patients not treated with long-term oxygen therapy; LTOT+, patients treated with
long-term oxygen therapy; FM, fat mass; FFM, fat-free mass; FFMI, fat-free mass index; SMI, skeletal mass index.
3.2. BBS, TUG, and Fall
BBS score was consistently lower, and TUG value was longer, in the faller group than in non-fallers
(40.5 ± 6.8 points vs 54.8 ± 1.8 points, and 15.4 ± 3.9 s vs 7.5 ± 1.4 s, respectively; both p < 0.001). There
was no overlap in the standard deviation of TUG values between fallers and non-fallers. Using the
12-s cut-off value [14], agreement between TUG and BBS for detection of fallers was excellent, with
a κ coefficient of 0.92 (p < 0.0001) in the whole population (Table 3). The sensitivity and specificity
of TUG were 95% and 97%, respectively. The area under the ROC curve was 0.99 (95% confidence
interval; 0.96; 1.00), giving the optimal diagnostic value of TUG at 10.9 s to detect falls (Figure 1).
Repeating the analysis with the 11-s cut-off value, we confirmed the excellent agreement (Table 3). This
threshold of 11 s for TUG nicely predicted fall incidence 6 months after the initial evaluation (Area
Under the Curve, AUC 0.87 (0.77–0.97)); sensitivity and specificity were 93.3% (68.1; 99.8) and 74.2%
(55.4; 88.1), respectively. Multivariable analysis adjusted for age (p = 0.81), gender (p = 0.45), BMI (p =
0.20), 6MWD (p = 0.84), previous falls (p = 0.50), and LTOT (p = 0.96) confirmed that TUG remained a
robust predictor of future falls with a predicted probability of 0.59 (0.50; 0.67) (p = 0.045).
Table 3. Agreement between Berg Balance Scale and Timed Up and Go test to detect the risk of fall.
All LTOT− LTOT+
With a cut-off value of 12 s for TUG
κ coefficient 0.92 0.87 0.92
Sensitivity (%) 95.0 (75.1–99.9) 80.0 (28.4–99.5) 100 (78.2–100)
Specificity (%) 96.7 (82.8–99.9) 100 (83.0–100) 90.0 (55.5–99.7)
PPV (%) 95.0 (75.1–99.9) 100 (39.8–100) 93.8 (69.8–99.8)
NPV (%) 96.7 (82.8–99.9) 95.2 (76.2–99.9) 100 (66.4–100)
With a cut–off value of 11 s for TUG
κ coefficient 0.96 1.00 0.92
Sensitivity (%) 100 (83.2; 100) 100 (47.8; 100) 90.0 (55.5–99.7)
Specificity (%) 96.7 (82.8; 99.9) 100 (83.2; 100) 93.8 (69.8–99.8)
PPV (%) 95.2 (76.2; 99.9) 100 (47.8; 100) 100 (66.4–100)
NPV (%) 100 (88.1; 100) 100 (83.2; 100) 90.0 (55.5–99.7)
Data are given as means and 95% confidence intervals. LTOT−, patients not treated with long-term oxygen
therapy; LTOT+, patients treated with long-term oxygen therapy; PPV, positive predictive value; NPV, negative
predictive value.
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4. Discussion
The main result of our study was the excellent prediction of likelihood of falling in the subsequent
6 months using a cut-off value of 11 s to complete the TUG, with a recurrence of fall in 62% of patients
in whom TUG was longer than this threshold. Moreover, we found an excellent agreement between
the Timed Up and Go test value and the BBS score for detection of fall risk in COPD patients who had
allowed us to determine the threshold value.
4.1. TUG as a Screening Test for Fall Risk
Our study was designed to validate use of TUG as a replacement for the BBS in detecting risk
of fall. A significantly slower time to perform TUG was previously reported in fallers compared to
non-fallers [4,14], and a cut-off value of 12 s was proposed to detect risk of fall with a sensitivity and
specificity of 74%. We built on these results to show that the predictive value of TUG was as h gh as that
of the BBS score, which r mains he gold standard in assessing balance control. The search for simple
field tests to assess m scle function and exercise capacity in COPD patients has recently intensified.
Thus, TUG may serve the double purpose of detecting fall risk wh le evaluating locomotor function.
To the best of our knowl dge, TUG has never been used prospectively to predict fall isk in
COPD patien s. We found that the cut-off value of 11 s precisely separates fallers nd non-fallers, and
predicts relapse of fall during the 6 following months. We acknowled e that our follow-up w s of
a short duration, but when a high risk of falling is detected then balance training should be rapidly
initiated [24], so our results are relevant to the design of optimal treatment r gimens.
The between-day 95% confid nce interval of minimal detectable ch nge in TUG was shown to be 3
s [25], and the variation after pulmonary rehabilitation ranged from 0.9 to 1.4 s [11]. The difference that
we report between fallers and non-fallers largely exce ded the i trinsic va iation of TUG, indicating
consistency and reinforcing the clinical utility of this test. In the LTOT+ group, carryi g the O2 canister
could increase the time taken to p rform TUG, but we foun a simi ar agreement between BBS and
TUG in the LTOT+ or LTOT− groups, which further highlights the consistency of the 11-s cut-off
value. TUG value is strongly correlated with both isometric and isokinetic quadricep PT [26], with
6MWD [11], a d also with the BODE index [14]. The response of TUG to pulmonary rehabilitation
and/or specific bal ce control training is known. Consequently, TUG could be used to assess the
ben fit of such trai ing programs for reducing fall risk. Howeve , we acknowledge that TUG did not
discr mi ate betw en the different components of postu al balance, and a more comprehensive test,
such as BBS, should be used for an in-depth assessment.
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4.2. Fall Incidence in COPD Patients
Although our patient sample was small, we confirmed the high prevalence of fall in COPD
patients in stable condition. Our study participants exhibited less severe bronchial obstruction and
were younger than those in the previous studies of Beauchamp et al. [4] and Roig et al. [2], but were
similar to those of Al Haddad et al. [14]. Only one of our study participants had been enrolled in a
rehabilitation program in the year prior to this study, and none presented a recent exacerbation. This is
important because acute exacerbation of COPD alters balance control test results relative to those of
patients in a steady state [8]. This demonstrates that patients’ balance control should be assessed when
they are stable. The onset of fall was two-fold higher in the LTOT+ group, but it was out of the scope
of this study to determine whether this higher prevalence was due to the severity of the disease or the
effect of chronic hypoxia on postural control. The two LTOT groups differed in COPD severity and
BMI but not in muscle mass, which might account for an altered postural control. Moreover, when
patients were interviewed by phone 6 months after the initial evaluation, we recorded another fall in
87% of the faller group, and only in 7% of the non-faller group. This confirms the ongoing elevated
risk of fall in this population.
4.3. Predictive Factors Associated with Falling
After adjusting for age, gender, and BMI, 6MWD (as a percentage of predicted value) remained the
only significant predictor of fall in our patients (Figure 2). However, the specific sensitivity of 6MWD is
unknown. Moreover, in COPD patients, walking distance is limited by muscle function and respiratory
capacity, and it is unlikely that 6MWD could assess the benefit of specific balance training exercises as
well as TUG. Age, gender, oxygen saturation, FEV1, and TUG predicted fall risk in COPD patients [14]
with similar ages and FEV1 values, but with lower mean 6MWDs than our study patients. We found
a consistently lower 6MWD and isokinetic quadriceps PT in fallers compared with non-fallers, but
BMI and appendicular muscle mass tended to be higher in the latter. This unexpected result may be
explained by selection bias, with a high number of obese COPD patients in our LTOT+ group. These
patients are known to present with a larger muscle mass than thin patients. Thus, alteration of postural
control due to excessive weight and associated locomotor limitations would be detected earlier than
muscle wasting. This point deserves further investigation.
4.4. Limitations of the Study
We acknowledge that the number of patients studied was limited. However, we found a similar
prevalence of fallers in previous studies, indicating that our population was not biased according
to this outcome. We also aimed to compare patients with and without LTOT to confirm a higher
prevalence of fall in the LTOT+ group, and the present study was designed to include equal numbers
of patients in both groups, which is not representative of the COPD population Using power analyses
based on previously published data, we calculated that 40 patients per group were sufficient to test
the agreement between BBS and TUG (according to Cohen’s test). As scheduled in the statistical
analysis plan, we performed an intermediary analysis that confirmed our hypothesis with a sample of
25 patients. This further emphasizes the power of TUG to detect fallers. However, the small number of
patients could limit multivariable regression analyses and explain why known determinants of falling
such as muscle mass/strength were not significant in the present study. Nonetheless, we included in
the multivariable models only clinically consistent factors (three to five predictive factors) and we feel
confident that our results are powerful and robust.
Fall occurrence was self-reported, as is common in similar studies, and we did not control for
the consequences of fall. Fall occurrence is often underestimated by patients unless it carries health
consequences such as injuries, emergency visits, or hospitalizations. We thus feel confident that, if
anything, we underestimated the number of falls. The study was proposed to consecutive patients and
regularly followed up in our respiratory unit, but we cannot rule out the possibility that participants
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were fearful of falling. Once again, we found a similar prevalence in other studies and we feel confident
that our recruitment was not unusually biased.
Finally, we did not assess the reproducibility of TUG, but the within-day variation of TUG in
COPD patients did not exceed 1 s on average, far lower than the difference reported between fallers
and non-fallers [27].
5. Conclusions
In individuals with COPD studied in stable respiratory condition, a cut-off value of 11 s predicts
the recurrence of falls in the next 6 months with sensitivity exceeding 90% and specificity at 74%. The
TUG shows excellent agreement with the Berg Balance Scale score for detecting the onset of fall in
the preceding year. We conclude that TUG could be easily incorporated into the scheduled functional
evaluations of COPD patients to prevent risk of fall and, when appropriate, to guide specific balance
training exercises.
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